Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.

MLA

Kim, Grace Hyun J., et al. “Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.” Arthritis & Rheumatology (Hoboken, N.J.), vol. 72, no. 2, Feb. 2020, pp. 316–25. EBSCOhost, https://doi.org/10.1002/art.41085.

APA

Kim, G. H. J., Tashkin, D. P., Lo, P., Brown, M. S., Volkmann, E. R., Gjertson, D. W., Khanna, D., Elashoff, R. M., Tseng, C.-H., Roth, M. D., & Goldin, J. G. (2020). Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis & Rheumatology (Hoboken, N.J.), 72(2), 316–325. https://doi.org/10.1002/art.41085

Chicago

Kim, Grace Hyun J, Donald P Tashkin, Pechin Lo, Matthew S Brown, Elizabeth R Volkmann, David W Gjertson, Dinesh Khanna, et al. 2020. “Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.” Arthritis & Rheumatology (Hoboken, N.J.) 72 (2): 316–25. doi:10.1002/art.41085.